PE Tech Report


Like this article?

Sign up to our free newsletter

Epidarex Capital adds to advisory board

Epidarex Capital (Epidarex), an early-stage, transatlantic life science venture fund, has appointed Dr William R Sellers, William Burns and Dr. Frank M Armstrong to its advisory board.

Epidarex is a leading investor in high growth life science and health technologies in under-ventured markets. The advisory board provides strategic guidance and advice to Epidarex and its transatlantic portfolio of 14 early-stage life science companies.
Kyp Sirinakis, Managing Partner and co-founder of Epidarex, says: “As a leading, early-stage venture capital firm, Epidarex builds high-growth life science companies in under-ventured markets. We are delighted to welcome our new advisory board members and look forward to benefitting from their depth of scientific and commercial experience.”

Like this article? Sign up to our free newsletter